Enovachem Recalls Estriol USP Micronized Due to Impurity Test Failures
Asclemed USA Inc. dba Enovachem Pharmaceuticals is recalling specific lots of Estriol, USP, (Micronized), 0.12 g, because additional testing found Out of Specification impurity test results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any specific illnesses, injuries, or hospitalizations, aligning with the rubric for moderate severity involving low-risk contamination or precautionary measures.
Plain-English summary
Asclemed USA Inc. dba Enovachem Pharmaceuticals is recalling specific lots of Estriol, USP, (Micronized), 0.12 g. The recall was initiated because additional testing revealed Out of Specification impurity test results for the product.
The affected product was distributed to six physician's offices within the state of California. The recall covers specific lot codes and expiration dates, including lots with expiration dates of 12/31/2020, 5/31/2021, and 8/31/2021.
Patients who have received this medication should contact their healthcare provider for guidance on next steps. The recall is classified as FDA Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37
- Manufacturer
- Asclemed USA Inc. dba Enovachem Pharmaceuticals
- Category
- Drug — Pharmaceutical
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot Code/Exp. Date: 11061901
- 11061803
- 11281804
- 11291804
- 04171902
- 05201901
- 08121902
- EXP 12/31/2020
- 08161901
- 10111903
- EXP 5/31/2021
- 11211904
- 10161901
- EXP 8/31/2021
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 3 recalled by Asclemed USA Inc. dba Enovachem Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Asclemed USA Inc. dba Enovachem Pharmaceuticals
See all →- LowEnovachem Recalls Methylprednisolone Tablets Due to Illegible Labeling
FDA (Drugs) · 2021-04-21
- ModerateEnovachem Recalls Estriol USP Micronized 0.24 g Due to Impurity Failures
FDA (Drugs) · 2020-01-15
- SevereEnovachem Recalls Estriol USP 0.06 g Due to Impurity Failures
FDA (Drugs) · 2020-01-15
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17